IDH1 and cancer: Mutations of the isocitrate dehydrogenases 1 and 2 (IDH1/2) were discovered as cancer drivers and it was observed that they occur in the catalytic site of IDH1/2, conferring to the mutant enzymes the ability to synthesize 2HG, responsible for triggering malignant transformation and leading to the development of some cancers [30].